Epic Trust Investment Advisors, LLC Abb Vie Inc. Transaction History

Epic Trust Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$144.61 - $166.54 $41,936 - $48,296	290 Added 18.95%	1,820 $290,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $28,215 - $33,837	-204 Reduced 11.76%	1,530 $247,000
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $26,305 - $30,170	-196 Reduced 10.16%	1,734 $233,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $265,606 - $337,672	1,930 New	1,930 $296,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Epic Trust Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Epic Trust Investment Advisors, LLC with notifications on news.